The Genomic Landscape of Early-Stage Ovarian High-Grade Serous Carcinoma.

Cheng, Zhao; Mirza, Hasan; Ennis, Darren P; Smith, Philip; Morrill Gavarró, Lena; Sokota, Chishimba; Giannone, Gaia; Goranova, Theodora; Bradley, Thomas; Piskorz, Anna; Lockley, Michelle; Kaur, Baljeet; Singh, Naveena; Tookman, Laura A; Krell, Jonathan; McDermott, Jacqueline; Macintyre, Geoffrey; Markowetz, Florian; Brenton, James D; McNeish, Iain A

Cheng, Zhao; Mirza, Hasan; Ennis, Darren P; Smith, Philip; Morrill Gavarró, Lena; Sokota, Chishimba; Giannone, Gaia; Goranova, Theodora; Bradley, Thomas; Piskorz, Anna; Lockley, Michelle; Kaur, Baljeet; Singh, Naveena; Tookman, Laura A; Krell, Jonathan; McDermott, Jacqueline; Macintyre, Geoffrey; Markowetz, Florian; Brenton, James D; McNeish, Iain A.

Affiliation

Cheng Z; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Mirza H; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Ennis DP; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Smith P; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Morrill Gavarró L; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Sokota C; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Giannone G; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Goranova T; Department of Oncology, University of Turin, Turin, Italy.
Bradley T; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Piskorz A; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Lockley M; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Singh N; Department of Cellular Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Tookman LA; Department of Pathology, Barts Healthcare NHS Trust, London, United Kingdom.
Krell J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
McDermott J; Department of Surgery and Cancer, Ovarian Cancer Action Research Centre, Imperial College London, London, United Kingdom.
Macintyre G; Department of Pathology, University College London Hospital NHS Trust, London, United Kingdom.
Markowetz F; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
Brenton JD; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.
McNeish IA; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, United Kingdom.

Clin Cancer Res ; 28(13): 2911-2922, 2022 07 01.

Article de En | MEDLINE | ID: mdl-35398881

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs de l'ovaire Type d'étude: Prognostic_studies Limites: Female / Humans / Middle aged Langue: En Journal: Clin Cancer Res Sujet du journal: NEOPLASIAS Année: 2022 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google